[Federal Register: January 19, 2005 (Volume 70, Number 12)]
[Page 3046]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

Veterinary Medicine Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Veterinary Medicine Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on January 31, 2005, from 8 
a.m. to 5:30 p.m.
    Location: DoubleTree Hotel, Plaza II and III, 1750 Rockville Pike, 
Rockville MD.
    Contact Person: Aleta Sindelar, Center for Veterinary Medicine 
(HFV-3), Food and Drug Administration, 7519 Standish Pl., Rockville MD 
20855, 301-827-4515, or e-mail: asindela@cvm.fda.gov. Please call the 
FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 
in the Washington, DC area), code 3014512548, for up-to-date 
information on this meeting.
    Agenda: The committee will discuss and make recommendations 
regarding the voluntary recall of the drug product, PROHEART 6 (NADA 
141-189), manufactured by Fort Dodge Animal Health. The committee will 
also discuss the Center for Veterinary Medicine's risk management 
strategy. The background material for this meeting will be posted on 
the Internet when available and no later than 1 business day before the 
meeting at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/ohrms/dockets/ac/04acdocs.htm (Scroll 

down to the appropriate committee link).
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by January 21, 
2005. Oral presentations from the public will be scheduled between 
approximately 1 p.m. and 2 p.m. on January 31, 2005. Time allotted for 
each presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person by January 21, 2005, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Aleta Sindelar at 
least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: January 11, 2005.
William K. Hubbard,
Associate Commissioner for Policy and Planning.
[FR Doc. 05-956 Filed 1-18-05; 8:45 am]